4.8 Article

A Pseudomonas aeruginosa TIR effector mediates immune evasion by targeting UBAP1 and TLR adaptors

Journal

EMBO JOURNAL
Volume 36, Issue 13, Pages 1869-1887

Publisher

WILEY
DOI: 10.15252/embj.201695343

Keywords

Pseudomonas; TIR domain; TLR adaptors; UBAP1; virulence

Funding

  1. FINOVI foundation under a Young Researcher Starting Grant
  2. Cystic Fibrosis French Foundation Vaincre la Mucovicidose (VLM) [RF20130500897]
  3. INSERM
  4. CNRS
  5. Region Rhones-Alpes ARC1 Sante fellowships
  6. VLM
  7. FINOVI
  8. Wellcome Trust PhD fellowship
  9. MRC [MR/N023250/1, MR/K001930/1, MR/J006874/1] Funding Source: UKRI
  10. Medical Research Council [MR/N023250/1, MR/J006874/1, MR/K001930/1] Funding Source: researchfish

Ask authors/readers for more resources

Bacterial pathogens often subvert the innate immune system to establish a successful infection. The direct inhibition of downstream components of innate immune pathways is particularly well documented but how bacteria interfere with receptor proximal events is far less well understood. Here, we describe a Toll/interleukin 1 receptor (TIR) domain-containing protein (PumA) of the multi-drug resistant Pseudomonas aeruginosa PA7 strain. We found that PumA is essential for virulence and inhibits NF-kappa B, a property transferable to non-PumA strain PA14, suggesting no additional factors are needed for PumA function. The TIR domain is able to interact with the Toll-like receptor (TLR) adaptors TIRAP and MyD88, as well as the ubiquitin-associated protein 1 (UBAP1), a component of the endosomal-sorting complex required for transport I (ESCRT-I). These interactions are not spatially exclusive as we show UBAP1 can associate with MyD88, enhancing its plasma membrane localization. Combined targeting of UBAP1 and TLR adaptors by PumA impedes both cytokine and TLR receptor signalling, highlighting a novel strategy for innate immune evasion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available